Meeting the growth of the UK Life Sciences industry

After the inaugural meeting of the new UK life sciences council, government research has highlighted an increase in turnover within the UK life sciences industry. With SMEs making up over 80% of business and almost a quarter of the industry’s employment, we looked into the key driving factors behind the £70 billion sector.

The development of growth within the UK Life Sciences industry

As a world leader in the Life Sciences sector, the UK are striving to lead the world’s next generation of medicine, technology and diagnostics to provide better healthcare for millions of patients.

New research has shown that the industry’s turnover exceeded £70 billion in 2017, creating over 241,000 jobs across the UK. With an increase in job opportunities allowing the industry to thrive, it’s clear this is a great time to work in life sciences. 

Contributing factors to growth

One of the biggest factors of this surge of turnover comes from the industry’s highest level of foreign investment in seven years. In 2016, £1.96 billion was raised through Life Science IPOs and follow-on offerings. Other factors include investments of £660 million across 67 UK projects in 2016.

Alongside these investments, the UK government have also proposed the life sciences sector deal, which will likely lead to further job opportunities within the industry. In its initial stage, there’s been a proposal of five digital innovation hubs and centres of excellence within the NHS for medical imagery and digital pathology. In addition to this, an investment of £65 million into three advanced therapy treatment centres in the UK has also been proposed. With these new investments, we can expect an increase of jobs to match the growth of these facilities.

The impact of growth within the recruitment process

Real Staffing’s Associate Business Manager, Hemish Ilangaratne, explains, ‘Quality Assurance (QA) and Regulatory Affairs have historically been our busiest markets. This is particularly due to QA demand, a shortage of Qualified Persons in the UK and the need to release products to market in accordance with GMP standards. With medicines being approved faster and a growing number of patents expiring, the demand from generic manufactures has also fuelled the need for QA and Regulatory professionals’.

With the industry growing at a rapid pace, our team are matching skilled professionals with new roles in the industry. With new developments in artificial intelligence, new regulations in medical devices and further growth expected for the industry, it’s a great time to be working in life sciences.

If you want to learn more about the opportunities available, use our job search to see the jobs we have on offer today.

Where is Singapore in its digital pharma journey?

11 Oct 2019

As the region’s technological hub, Singapore’s digital journey has rapidly evolved with sophisticated technologies and innovation. As such, the nation is well-poised to transform the future of pharma within Southeast Asia. But what exactly is the impact of digital disruption in the sector, what does it mean and how is it going to impact the pharmaceutical scene?


07 Oct 2019

As part of our ‘Inspired by you’ initiative we are celebrating the amazing work of our clients and candidates. We’d love to hear your story and what’s driven your passion for the life sciences industry!

Digital Outcomes and Specialists 4 Approved Suppliers

02 Oct 2019

We are delighted to announce that our Public Sector division have been awarded a place on the Crown Commercial Services Digital Outcomes and Specialists 4 framework

Not every contract assignment should be determined as Inside IR35

24 Sep 2019

An important message to any end client who is considering making blanket IR35 determinations.

Tags: IR35